Evolution and clinical significance of the T cell proliferative and cytokine response directed against the fibronectin binding antigen 85 complex of bacillus Calmette-Guerin during intravesical treatment of superficial bladder cancer

MLA

Zlotta, A. R., et al. “Evolution and Clinical Significance of the T Cell Proliferative and Cytokine Response Directed against the Fibronectin Binding Antigen 85 Complex of Bacillus Calmette-Guerin during Intravesical Treatment of Superficial Bladder Cancer.” Cancer Weekly Plus, 24 Feb. 1997, p. 29. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.19175441&authtype=sso&custid=ns315887.

APA

Zlotta, A. R., Drowart, A., Vanvooren, J. P., Decock, M., Pirson, M., Palfliet, K., Jurior, F., Vanonckelen, A., Simon, J., Schulman, C. C., & Huygen, K. (1997, February 24). Evolution and clinical significance of the T cell proliferative and cytokine response directed against the fibronectin binding antigen 85 complex of bacillus Calmette-Guerin during intravesical treatment of superficial bladder cancer. Cancer Weekly Plus, 29.

Chicago

Zlotta, A.R., A. Drowart, J.P. Vanvooren, M. Decock, M. Pirson, K. Palfliet, F. Jurior, et al. 1997. “Evolution and Clinical Significance of the T Cell Proliferative and Cytokine Response Directed against the Fibronectin Binding Antigen 85 Complex of Bacillus Calmette-Guerin during Intravesical Treatment of Superficial Bladder Cancer.” Cancer Weekly Plus, February 24. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.19175441&authtype=sso&custid=ns315887.